Tocilizumab as a potential treatment in Schnitzler syndrome.
Kluger
Nicolas
N
Bessis
Didier
D
Guillot
Bernard
B
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D019873:Schnitzler Syndrome / Q000188:drug therapy* / Q000503:physiopathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007375:Interleukin-1; C502936:tocilizumab